The Laval Project has been completed and is awaiting licencing from Health Canada. The facility is currently 10,000 sf and will be expanded to 37,000 sf. Once the appropriate licences are received from Health Canada, it will enable MYM to produce and market its branded THC and CBD medical products across Canada. Health Canada does not provide dates as to when they'll approve license applications, any further questions regarding Licensing updates please contact: Terry Brown, Investor Relations - terry.brown@mym.ca